Nav1.7 blockers (Newron)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNav1.7 blockers (Newron)
Drug Alias Namevoltage gated sodium channel inhibitors (Axxam/Newron/Primm)Nav1.7 blockers (Axxam/Newron/Primm)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated sodium channels blockers
TargetsVoltage-gated sodium channels
Therapy Area/IndicationsPainCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAxxam Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAxxam SpaPrimm SrLNewron Pharmaceuticals Spa
Active IndicationsN/A
Inactive IndicationsPainCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A